ArticleOncology research2020

VASH2 Promotes Cell Proliferation and Resistance to Doxorubicin in Non-Small Cell Lung Cancer via AKT Signaling.

Xiangbin Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.